The Canary In Big Blue’s Mainframe: Why IBM’s Q3 Bust Marks A Turning Point

IBM’s board and C-suite have eschewed the demanding work of technological innovation and investment in the future, and, instead, have turned the world’s leading technology company into a stock buyback machine on steroids.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.